Revlimid (lenalidomide capsules) — Cigna
Follicular Lymphoma
Initial criteria
- Patient age ≥ 18 years
- The medication is used in combination with rituximab OR The medication is used in combination with Gazyva (obinutuzumab intravenous infusion) OR Patient has tried at least one other regimen
Approval duration
1 year